|
Workshop
"ECONOMICS OF IMMUNIZATION"
22-23 August 2002, Oslo
List of Presentations:
Introduction by Co-Chairs
Powerpoint 345k
-
Dr. Tore Godal, Executive Secretary, GAVI, Switzerland
Overview presentation What do we know about the economics of
immunization?
Powerpoint 91k
Investing in immunization: The diversity of country situations
Powerpoint 408k
-
Mr. Jonas Gahr Støre, Director and Chairman of the Board, ECON,
Norway
What kind of economic information do decision-makers need for resource
allocation?
-
a) Developing country perspective
-
H.E. Dr. Pascoal M. Mocumbi, Prime Minister, Mozambique
-
H.E. Mr. Donald Kaberuka, Minister of Finance, Rwanda
-
b) Donor perspective
Powerpoint 34k
-
Ms Marion Kelly, DFID, U.K.
Economic benefits from investing in child health and immunization
Powerpoint 1062k
-
Prof. David Canning, Department of Economics, Queen's University,
Belfast, U.K.
Finance for health in low-income countries: Findings of the Commission
on Macroeconomics and Health
-
Prof. Alan Tait, University of Kent at Canterbury, U.K.
GAVI Financing Task Force: GAVI Financial Sustainability plans and
process
Powerpoint 225k; GAVI Immunization Financing Database
Powerpoint 525k
-
Mr. Dan Kress, Abt Associates, U.S.A.
CHOICE: a new WHO database to provide cost-effectiveness data for all
major health interventions
-
Dr. Dan Chishom, WHO, Switzerland
Catalytic vaccine financing
Powerpoint 101k
-
Mr. Raj Shah, The Gates Foundation, USA
Health system approaches to increase coverage
Powerpoint 175k
-
Dr. Sam Adjei's presentation delivered by Tore Godal
Challenges in reaching higher coverage, from a McKinsey perspective
PDF 93k
-
Mr. Michael Conway, McKinsey Consulting, U.S.A.
Consider and discuss research directions
-
Prof. David Canning, Dr. Richard Bumgarner, Dr. Sigrun Mogedal
Conclusions and next steps
|
|